Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Harvey

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Health Technology Assessment (Winchester, England)|September 23, 2015
Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failureAndrew L Clark, Miriam Johnson, Caroline Fairhurst, et al.
BMC Public Health|November 19, 2008
Physical activity and dietary behaviour in a population-based sample of British 10-year old children: the SPEEDY study (Sport, Physical activity and Eating behaviour: environmental Determinants in Young people)Esther M F van Sluijs, Paula M L Skidmore, Kim Mwanza, et al.
Thorax|September 4, 2012
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary careJane Rebecca Smith, Michael J Noble, Stanley Musgrave, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 27, 2018
Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP StudyEugene McCloskey, Helena Johansson, Nicholas C Harvey, et al.
Lancet (London, England)|December 20, 2017
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trialLee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Health Technology Assessment (Winchester, England)|September 23, 2015
Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failureAndrew L Clark, Miriam Johnson, Caroline Fairhurst, et al.
BMC Public Health|November 19, 2008
Physical activity and dietary behaviour in a population-based sample of British 10-year old children: the SPEEDY study (Sport, Physical activity and Eating behaviour: environmental Determinants in Young people)Esther M F van Sluijs, Paula M L Skidmore, Kim Mwanza, et al.
Thorax|September 4, 2012
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary careJane Rebecca Smith, Michael J Noble, Stanley Musgrave, et al.
The European Respiratory Journal|November 10, 2018
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertensionEmilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, et al.
Health Technology Assessment (Winchester, England)|May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) reviewJonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.
Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 27, 2018
Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP StudyEugene McCloskey, Helena Johansson, Nicholas C Harvey, et al.
Lancet (London, England)|December 20, 2017
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trialLee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Pageof 9